Rapport Therapeutics (RAPP) Shares Sink 20% After Hours
Rapport Therapeutics stock falls after hours as investors assess proposed stock and convertible notes offerings.
Share
Why It Matters
Rapport is selling new stock and special bonds to raise money. When a company does this, it can mean the existing stock gets diluted, so watch what they plan to do with the cash.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.